EX-99.1 2 tm2513549d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Waystar Reports First Quarter 2025 Results

Q1 revenue growth of 14% year-over-year

Q1 net income of $29.3 million and non-GAAP net income of $58.7 million

Q1 net income margin of 11%; adjusted EBITDA margin of 42%

Raising revenue and adjusted EBITDA guidance for 2025

LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the first quarter ended March 31, 2025.

“Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins exceeding 40%, and our fourth consecutive quarter of double-digit revenue growth as a public company,” said Matt Hawkins, Chief Executive Officer of Waystar. “We also advanced our innovation roadmap with the launch of Waystar AltitudeAI, equipping clients with powerful AI capabilities that streamline workflows and improve financial performance. With a resilient foundation and durable growth model, we have the visibility and confidence to raise our full-year revenue and adjusted EBITDA guidance.”

First Quarter 2025 Financial Highlights

Revenue of $256.4 million, up 14% year-over-year

Net income of $29.3 million, GAAP net income per diluted share of $0.16, and net income margin of 11%

Non-GAAP net income of $58.7 million and non-GAAP net income per diluted share of $0.32

Adjusted EBITDA of $107.7 million and adjusted EBITDA margin of 42%

Cash flow from operations of $64 million and unlevered free cash flow of $79 million

Key Metrics and Revenue Disaggregation

1,244 clients contributed over $100,000 in LTM revenue, up 15% year-over-year

Net revenue retention rate (NRR) of 114% over LTM ending March 31, 2025

Subscription revenue of $125.0 million, up 18% year-over-year

Volume-based revenue of $129.9 million, up 11% year-over-year

Financial Outlook

As of April 30, 2025, Waystar provides the following guidance for its full fiscal year 2025.¹

Total revenue is expected to be between $1.006 billion and $1.022 billion

Adjusted EBITDA is expected to be between $406 million and $414 million

Non-GAAP net income is expected to be between $241 million and $247 million

Diluted non-GAAP net income per share is expected to be between $1.31 and $1.34

Webcast Information

Waystar's financial results will be discussed on a conference call scheduled at 4:30 p.m. Eastern Daylight Time today, April 30, 2025. A live audio conference call will be available on Waystar's website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real time. This earnings release and the related Current Report on Form 8-K filed April 30, 2025, can be accessed on the Investor Relations page of the company’s website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission (“SEC”) filings, and public conference calls and webcasts.

Non-GAAP Financial Measures

To supplement the consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles (“GAAP”), this press release contains certain non-GAAP financial measures as defined below. We present non-GAAP financial measures as supplemental measures of financial performance that are not required by, or presented in accordance with, GAAP. We believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses adjusted EBITDA and adjusted EBITDA margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide.

¹ We have not reconciled the forward-looking adjusted EBITDA, non- GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

Adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.

The following non-GAAP financial measures and key performance metrics are defined below:

Adjusted EBITDA and adjusted EBITDA Margin

We define adjusted EBITDA as net income / (loss) before interest expense, net, income tax expense / (benefit), depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements and IPO and secondary offering costs. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.

Non-GAAP Net Income / (loss) and Non-GAAP Net Income / (loss) Per Share

We define non-GAAP net income as GAAP net income / (loss) excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, costs related to our IPO, and the Secondary Offering, and costs related to amended debt agreements and amortization of intangibles. The tax effects of the adjustments are calculated using a management estimated annual effective non-GAAP tax rate of 21%, which is based on our statutory federal tax rate and provides consistency across interim reporting periods by eliminating the effects of non-recurring and period specific items. Due to the differences in the tax treatment of items excluded from non-GAAP net income, our estimate tax rate on non-GAAP net income may differ from our GAAP tax rate. Non-GAAP net income per share is shown on both a basic and diluted basis and is defined as non-GAAP net income divided by the basic or diluted weighted-average shares, respectively.

Unlevered Free Cash Flow

We define unlevered free cash flow as cash from operations plus cash interest paid less capital expenses.

Net Debt

We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents and investment securities.

Adjusted Net Leverage Ratio

We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.

Key Performance Metrics

Net Revenue Retention Rate

Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.

Customer Count with >$100,000 of Revenue

We regularly monitor and review our count of clients who generate more than $100,000 of revenue.

Our count of clients who generate more than $100,000 of revenue is based on an accumulation of the amounts invoiced to clients over the preceding twelve months. The invoices for acquired clients are included starting in the first full calendar quarter after the date of acquisition.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar’s expectations relating to future operating results and financial position, including full year 2025, and future periods; the performance of our new product offerings; our industry and market opportunities, business strategy, goals, and expectations concerning our market position, future operations, margins and profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” “outlook,” the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2025.

The forward-looking statements contained in this press release are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients’ timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients’ and their vendors’ networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform; the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; our use of “open source” software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; healthcare laws and data privacy and security laws and regulations governing our processing of personal information; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; consumer protection laws and regulations; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of “Risk Factors” in the Company’s 10K filed with the Securities and Exchange Commission (the “SEC”) on February 18, 2025, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

About Waystar

Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar’s enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Waystar Holding Corp.

Unaudited Condensed Consolidated Statements of Operations

(in Thousands, Except for Share and Per Share Data)

	Three months ended March 31,
	2025			2024
Revenue	$	256,435		$	224,792
Operating expenses
Cost of revenue (exclusive of depreciation and amortization expenses)		83,345			75,192
Sales and marketing		40,123			33,780
General and administrative		23,300			26,135
Research and development		11,078			10,320
Depreciation and amortization		33,380			44,174
Total operating expenses		191,226			189,601
Income from operations		65,209			35,191
Other expense
Interest expense		(18,257	)		(55,812	)
Related party interest expense		(643	)		(1,372	)
Income/(loss) before income taxes		46,309			(21,993	)
Income tax expense/(benefit)		17,040			(6,061	)
Net income/(loss)	$	29,269		$	(15,932	)
Net income/(loss) per share:
Basic	$	0.17		$	(0.13	)
Diluted	$	0.16		$	(0.13	)
Weighted-average shares outstanding:
Basic		172,188,237			121,675,298
Diluted		180,691,994			121,675,298

Waystar Holding Corp.

Unaudited Condensed Consolidated Balance Sheets

(in Thousands, Except for Share and Per Share Data)


	March 31, 2025			December 31, 2024
Assets
Current assets
Cash and cash equivalents	$	223,995		$	182,133
Restricted cash		25,723			22,449
Investment securities		24,419			—
Accounts receivable, net of allowance of $5,897 at March 31, 2025 and $5,885 at December 31, 2024		147,264			145,235
Income tax receivable		—			2,838
Prepaid expenses		16,900			14,414
Other current assets		2,249			3,972
Total current assets		440,550			371,041
Property, plant and equipment, net		46,645			46,731
Operating lease right-of-use assets, net		9,896			10,820
Intangible assets, net		1,010,933			1,039,049
Goodwill		3,019,999			3,019,999
Deferred costs		85,088			82,815
Other long-term assets		6,067			6,549
Total assets	$	4,619,178		$	4,577,004
Liabilities and stockholders’ equity
Current liabilities
Accounts payable	$	45,064		$	47,365
Accrued compensation		15,857			31,589
Aggregated funds payable		25,253			22,059
Other accrued expenses		25,646			15,930
Deferred revenue		11,348			10,527
Current portion of long-term debt		11,228			11,311
Related party current portion of long-term debt		440			357
Current portion of operating lease liabilities		5,538			5,591
Current portion of finance lease liabilities		926			904
Total current liabilities		141,300			145,633
Long-term liabilities
Deferred tax liability		104,927			100,523
Long-term debt, net, less current portion		1,174,879			1,185,411
Related party long-term debt, net, less current portion		43,356			35,211
Operating lease liabilities, net of current portion		11,785			13,133
Finance lease liabilities, net of current portion		11,049			11,290
Deferred revenue–LT		5,692			5,739
Other long-term liabilities		278			278
Total liabilities		1,493,266			1,497,218
Commitments and contingencies (Note 20)
Stockholders’ equity
Preferred stock $0.01 par value - 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; zero shares issued or outstanding as of March 31, 2025 and December 31, 2024, respectively		—			—
Common stock $0.01 par value - 2,500,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; 172,963,709 and 172,108,240 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively		1,730			1,722
Additional paid-in capital		3,315,497			3,298,083
Accumulated other comprehensive income		316			881
Accumulated deficit		(191,631	)		(220,900	)
Total stockholders’ equity		3,125,912			3,079,786
Total liabilities and stockholders’ equity	$	4,619,178		$	4,577,004

Waystar Holding Corp.

Unaudited Condensed Consolidated Statements of Cash Flows

(in Thousands)


	Three months ended March 31,
	2025			2024
Cash flows from operating activities
Net income/(loss)	$	29,269		$	(15,932	)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities
Depreciation and amortization		33,380			44,174
Stock-based compensation		6,744			2,528
Provision for bad debt expense		1,255			556
Loss on extinguishment of debt		—			8,869
Deferred income taxes		4,569			(19,591	)
Amortization of debt discount and issuance costs		667			1,680
Changes in:
Accounts receivable		(3,284	)		(10,274	)
Income tax refundable		2,838			6,811
Prepaid expenses and other current assets		(1,460	)		(3,538	)
Deferred costs		(2,222	)		(4,230	)
Other long-term assets		324			(325	)
Accounts payable and accrued expenses		(8,130	)		(1,280	)
Deferred revenue		775			1,711
Operating lease right-of-use assets and lease liabilities		(476	)		(429	)
Net cash provided by operating activities		64,249			10,730
Cash flows from investing activities
Purchase of property and equipment and capitalization of internally developed software costs		(5,426	)		(5,560	)
Purchase of investment securities		(24,431	)		—
Net cash used in investing activities		(29,857	)		(5,560	)
Cash flows from financing activities
Change in aggregated funds liability		3,194			3,538
Repurchase of shares		—			(225	)
Proceeds from exercise of common stock options		10,686			71
Proceeds from issuances of debt, net of creditor fees		—			535,209
Payments on debt		(2,917	)		(516,774	)
Third-party fees paid in connection with issuance of new debt		—			(1,410	)
Finance lease liabilities paid		(219	)		(199	)
Net cash provided by financing activities		10,744			20,210
Increase in cash and cash equivalents during the period		45,136			25,380
Cash and cash equivalents and restricted cash–beginning of period		204,582			45,428
Cash and cash equivalents and restricted cash–end of period	$	249,718		$	70,808
Supplemental disclosures of cash flow information
Interest paid	$	19,960		$	40,513
Cash taxes paid (refunds received), net		532			(54	)
Non-cash investing and financing activities
Fixed asset purchases in accounts payable		56			518
Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement
Balance sheet
Cash and cash equivalents		223,995			57,337
Restricted cash		25,723			13,471
Total		249,718			70,808

Waystar Holding Corp.

Reconciliation of Adjusted EBITDA

(in thousands)

(unaudited)

	Three months ended
	March 31,
	2025			2024
Net income/(loss)		29,269			(15,932	)
Interest expense		18,900			57,184
Income tax expense/(benefit)		17,040			(6,061	)
Depreciation and amortization		33,380			44,174
Stock-based compensation expense		6,744			2,528
Acquisition and integration costs		229			302
Costs related to amended debt agreements		-			10,402
IPO and Secondary Offering expenses		1,430			164
Other (a)		754			-
Adjusted EBITDA		107,746			92,761
Revenue		256,435			224,792
Net income/(loss) margin		11.4	%		(7.1	%)
Adjusted EBITDA margin		42.0	%		41.3	%

(a) Adjustments relate to additional lease costs due to the relocation of our Louisville office totaling $0.2 million and executive severance totaling $0.5 million for the three months ended March 31, 2025.

Waystar Holding Corp.

Reconciliation of Non-GAAP Operating Expenses

(in thousands)

(unaudited)

	Three months ended
	March 31,
	2025			2024
Cost of revenue (exclusive of depreciation and amortization expenses)		83,345			75,192
Less: Stock-based compensation expense		(231	)		(122	)
Less: Acquisition and integration costs		-			(31	)
Cost of revenue (exclusive of depreciation and amortization expenses), adjusted		83,114			75,039

Sales and marketing		40,123			33,780
Less: Stock-based compensation expense		(1,392	)		(478	)
Sales and marketing, adjusted		38,731			33,302

General and administrative		23,300			26,135
Less: Stock-based compensation expense		(4,106	)		(1,540	)
Less: Acquisition and integration costs		(107	)		(83	)
Less: Costs related to amended debt agreements		-			(10,402	)
Less: IPO and Secondary Offering expenses		(1,430	)		(164	)
Less: Other (a)		(754	)		-
General and administrative, adjusted		16,903			13,946

Research and development		11,078			10,320
Less: Stock-based compensation expense		(1,015	)		(388	)
Less: Acquisition and integration costs		(122	)		(188	)
Research and development, adjusted		9,941			9,744

Depreciation and amortization		33,380			44,174
Less: Intangible amortization		(28,115	)		(39,080	)
Depreciation and amortization, adjusted		5,265			5,094

Income tax expense/(benefit)		17,040			(6,061	)
Plus: Tax effect of adjustments		7,827			11,020
Income tax expense, adjusted		24,867			4,959

Waystar Holding Corp.

Reconciliation of Non-GAAP Net Income

(in thousands, except share and per share amounts)

(unaudited)

	Three months ended
	March 31,
	2025			2024
Net income/(loss)		29,269			(15,932	)
Stock based compensation expense		6,744			2,528
Acquisition and integration costs		229			302
Costs related to amended debt agreements		-			10,402
IPO and Secondary Offering expenses		1,430			164
Other (a)		754			-
Intangible amortization		28,115			39,080
Tax effect of adjustments		(7,827	)		(11,020	)
Non-GAAP net income		58,714			25,524

Non-GAAP net income per share, basic		0.34			0.21
Non-GAAP net income per share, diluted		0.32			0.20

Weighted average shares used in computing basic Non-GAAP net income per share		172,188,237			121,675,298
Weighted average shares used in computing diluted Non-GAAP net income per share		180,691,994			127,095,087

Waystar Holding Corp.

Reconciliation of Unlevered Free Cash Flow

(in thousands)

(unaudited)

	Three months ended
	March 31,
	2025			2024
Net cash provided by operating activities		64,249			10,730
Interest paid		19,960			40,513
Purchase of property and equipment and capitalization of internally developed software costs		(5,426	)		(5,560	)
Unlevered free cash flow		78,783			45,683

Waystar Holding Corp.

Reconciliation of Net Debt

(in thousands)

(unaudited)

	March 31,
	2025			2024
First lien term loan facility outstanding debt, current		11,668			22,000
First lien term loan facility outstanding debt, net of current portion		1,148,960			2,178,000
Receivables facility outstanding debt		80,000			70,000
Cash and cash equivalents		(223,995	)		(57,337	)
Investment securities		(24,419	)		-
Net debt		992,214			2,212,663

Trailing Twelve Months Adjusted EBITDA		398,481			343,753

Adjusted Gross leverage ratio		3.1	x		6.6	x
Adjusted Net leverage ratio		2.5	x		6.4	x

Waystar Holding Corp.

Reconciliation of Trailing Twelve Months (TTM) Adjusted EBITDA

(in thousands)

(unaudited)

	Three Months Ended									TTM
	March 31,		December 31,		September 30,		June 30,			March 31,
	2025		2024		2024		2024			2025
Net income/(loss)		29,269		19,079		5,413		(27,685	)		26,076
Interest expense		18,900		20,086		18,459		50,541			107,986
Income tax expense/(benefit)		17,040		13,978		3,274		(14,611	)		19,681
Depreciation and amortization		33,380		37,996		60,185		44,276			175,837
Stock-based compensation expense		6,744		7,037		7,903		36,969			58,653
Acquisition and integration costs		229		163		188		206			786
Costs related to amended debt agreements		-		1,262		106		2,368			3,736
IPO and Secondary Offering expenses		1,430		26		109		1,841			3,406
Other (a)		754		526		1,040		-			2,320
Adjusted EBITDA		107,746		100,153		96,677		93,905			398,481

(a) Adjustments relate to additional lease costs due to the relocation of our Louisville office and executive severance

Media Contact

Kristin Lee
kristin.lee@waystar.com

Investor Contact

Sandy Draper

investors@waystar.com

502-238-9511